Lisata Therapeutics, Inc. (LSTA) Total liabilities 2015–2024
Lisata Therapeutics, Inc. (LSTA) total liabilities at each fiscal year-end, per SEC filings.
$3.1MFY2024 · since FY2015: $30.0M → $3.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $3.1M | -44.7% |
| FY2023 | $5.7M | -16.4% |
| FY2022 | $6.8M | +1.3% |
| FY2021 | $6.7M | — |
| FY2015 | $30.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More LSTA financial trends
LSTA RevenueLSTA Net incomeLSTA Net marginLSTA Gross profitLSTA Gross marginLSTA Operating incomeLSTA Operating marginLSTA Operating cash flowLSTA Free cash flowLSTA Capital expendituresLSTA Return on equityLSTA Stock buybacksLSTA Dividends paidLSTA Total assetsLSTA Shareholders’ equityLSTA overview →